| 09:30 - 11:30 | 324 | Chinese programme 2021 | Language session |
| 09:30 - 11:00 | 325 | Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD | Oral Presentation |
| 09:30 - 11:00 | 326 | Acute and chronic lung infections in children | Oral Presentation |
| 09:30 - 11:00 | 327 | Respiratory infections and bronchiectasis outcomes | Oral Presentation |
| 09:30 - 11:00 | 328 | New evidence from longitudinal COPD cohorts and other key studies | Oral Presentation |
| 09:30 - 11:00 | 329 | Hot news from the pleura | Hot topics |
| 09:30 - 10:10 | 330 | ERS guidelines on non-continuous positive airway pressure therapies in obstructive sleep apnoea | Guidelines session |
| 09:30 - 11:00 | 331 | Living with a new norm: providing quality care in the post-COVID era | Symposium |
| 09:30 - 11:00 | 332 | Pulmonary vascular diseases | State of the art session |
| 09:30 - 11:00 | 333 | ALERT: Asthma in adult, in children and ILDs | Clinical trials session |
| 09:30 - 11:00 | 334 | Optimising outcomes of lung transplantation: how to move forward? | Oral Presentation |
| 10:00 - 12:00 | 335 | Interventional pulmonology | Skills lab |
| 10:20 - 11:00 | 337 | High flow nasal cannula in adults with acute respiratory failure | Guidelines session |
| 11:15 - 12:45 | 343 | A multidisciplinary approach to the management of chronic respiratory diseases | Oral Presentation |
| 11:15 - 12:45 | 344 | COPD pharmacology: from basic science to real-world data | Oral Presentation |
| 11:15 - 12:45 | 345 | Causes and consequences of paediatric respiratory diseases | Oral Presentation |
| 11:15 - 12:45 | 346 | New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes | Oral Presentation |
| 11:15 - 12:45 | 347 | Thoracic oncology | State of the art session |
| 11:15 - 12:45 | 348 | How science conquered COVID-19: from big platform trials to patients | Hot topics |
| 11:15 - 12:45 | 349 | Maintenance of the beneficial effects of pulmonary rehabilitation: the role of digital health | Symposium |
| 11:15 - 12:45 | 350 | Pulmonary embolism: special situations | Symposium |
| 11:15 - 12:45 | 351 | Precision medicine in respiratory infections | Symposium |
| 11:15 - 12:45 | 352 | From pathophysiology to different diagnostic modalities in sleep disordered breathing | Oral Presentation |
| 11:45 - 13:00 | 353 | CCC Airway diseases | Challenging clinical cases |
| 12:10 - 12:50 | 354 | Spirometry and oscillometry | Skills lab |
| 13:00 - 15:00 | 360 | Pulmonary rehabilitation | Skills lab |
| 13:15 - 14:15 | 367 | Biomarkers and risk factors in childhood asthma | E-poster |
| 13:15 - 14:15 | 368 | Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease | E-poster |
| 13:15 - 14:15 | 369 | Accurate diagnosis and prediction of malignant pleural disease | E-poster |
| 13:15 - 14:15 | 370 | Clinical features and new biomarkers of asthma, COPD and chronic cough | E-poster |
| 13:15 - 14:15 | 371 | Clinical problems associated with cough, pleura and respiratory health status | E-poster |
| 13:15 - 14:15 | 372 | Paediatric respiratory infections: chronic infection, vaccination and lung function | E-poster |
| 13:15 - 14:15 | 373 | Assessing the impact of COVID-19 on lung function | E-poster |
| 13:15 - 14:15 | 374 | Occupational COVID-19 and respiratory infections | E-poster |
| 13:15 - 14:15 | 375 | COVID - 19, smoking and e-cigarettes | E-poster |
| 13:15 - 14:15 | 376 | New insights into lung function testing | E-poster |
| 13:15 - 14:15 | 377 | Imaging in COVID-19 | E-poster |
| 13:15 - 14:15 | 378 | COVID - 19 epidemiology | E-poster |
| 13:15 - 14:15 | 379 | Translational and other aspects of idiopathic interstitial pneumonia | E-poster |
| 13:15 - 14:15 | 380 | What's new in respiratory problems in rare and systemic diseases | E-poster |
| 13:15 - 14:15 | 381 | Respiratory failure in COVID19 and beyond | E-poster |
| 13:15 - 14:15 | 382 | The ongoing threat of drug-resistant tuberculosis | E-poster |
| 13:15 - 14:15 | 383 | Chronic airway, interstitial, pleural and neoplastic diseases | E-poster |
| 13:15 - 14:15 | 384 | Cystic fibrosis in children: various aspects | E-poster |
| 13:15 - 14:15 | 385 | Asthma inhalers: new devices and adherence | E-poster |
| 13:15 - 14:15 | 386 | Oncology, the mediastinum and infectious lung disease | E-poster |
| 13:15 - 14:15 | 387 | Biomarkers to phenotype COPD: prediction of exacerbations | E-poster |
| 13:15 - 14:15 | 388 | Digital health interventions in respiratory medicine | E-poster |
| 13:15 - 14:15 | 389 | Primary ciliary dyskinesia and tracheostomy | E-poster |
| 13:15 - 14:15 | 390 | COVID - 19 | E-poster |
| 13:15 - 14:15 | 391 | Challenging problems in lung transplantation | E-poster |
| 13:15 - 14:15 | 392 | COPD burden, epidemiology and management | E-poster |
| 13:15 - 14:15 | 393 | Advances in asthma treatment | E-poster |
| 13:15 - 14:15 | 394 | Thoracic ultrasound as a bedside clinical tool | E-poster |
| 13:15 - 14:15 | 395 | Therapies for respiratory diseases in primary care and COVID - 19 | E-poster |
| 13:15 - 14:15 | 396 | Home mechanical ventilation: organisation and outcomes | E-poster |
| 13:15 - 14:15 | 397 | Pulmonary hypertension in the COVID-19 pandemic and beyond | E-poster |
| 13:15 - 14:15 | 398 | Molecular pathology and cell biology of pulmonary diseases | E-poster |
| 13:15 - 14:15 | 399 | Primary care diagnosis and multimorbidities | E-poster |
| 13:15 - 14:15 | 400 | COVID - 19 risk predictions | E-poster |
| 13:15 - 14:15 | 401 | COVID - 19 treatments | E-poster |
| 13:15 - 14:15 | 402 | Advanced in vitro models for drug discovery | E-poster |
| 13:15 - 14:15 | 403 | Biomarkers to phenotype asthma: prediction of exacerbations | E-poster |
| 13:15 - 14:15 | 404 | Advances in asthma treatment: monoclonal antibodies | E-poster |
| 13:15 - 14:15 | 405 | Interstitial lung disease around the world | E-poster |
| 13:15 - 14:15 | 406 | COVID19, acute respiratory failure and basic science | E-poster |
| 13:15 - 14:15 | 407 | Pleural disease and bronchoscopic lung volume reduction | E-poster |
| 13:15 - 14:15 | 408 | COVID - 19 around the globe | E-poster |
| 13:15 - 14:15 | 409 | Prediction of exacerbations in patients with COPD | E-poster |
| 13:15 - 14:15 | 410 | COVID-19 and management of lung cancer | E-poster |
| 13:15 - 14:15 | 411 | E-health for COVID-19 | E-poster |
| 13:15 - 14:15 | 412 | Biological and functional markers of COVID-19 | E-poster |
| 13:15 - 14:15 | 413 | A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases | E-poster |
| 13:15 - 14:15 | 414 | Paediatric allergic asthma: novel therapeutics and monitoring approaches | E-poster |
| 14:45 - 16:00 | 415 | CCC Thoracic oncology | Challenging clinical cases |
| 14:45 - 16:15 | 416 | Remote monitoring of respiratory patients | Oral Presentation |
| 14:45 - 16:15 | 417 | Respiratory disorders in neonatal and paediatric intensive care | Oral Presentation |
| 14:45 - 16:15 | 418 | Acute COVID - 19 | Oral Presentation |
| 14:45 - 16:15 | 419 | Better understanding of sarcoidosis: new keys | Oral Presentation |
| 14:45 - 16:15 | 420 | Emerging imaging biomarkers in lung disease | Symposium |
| 14:45 - 16:15 | 421 | LoF Airway diseases? | Lungs on fire |
| 14:45 - 16:15 | 422 | Orphan childhood disease: nicotine and cannabis addiction | Symposium |
| 14:45 - 16:15 | 423 | Sleep and breathing disorders | State of the art session |
| 14:45 - 16:15 | 424 | Emerging data for the management of respiratory tract infections | Respiratory medicine meets other disciplines |
| 14:45 - 16:15 | 425 | Severe acute respiratory failure | Oral Presentation |
| 16:30 - 18:00 | 432 | Hot topics in thoracic oncology | Joint session |
| 16:30 - 18:00 | 433 | Keys to success in science | Symposium |
| 16:30 - 18:00 | 434 | Respiratory function after COVID-19 and mechanical ventilation | Oral Presentation |
| 16:30 - 18:00 | 435 | Exacerbations of chronic respiratory diseases, including SARS-CoV-2 | Oral Presentation |
| 16:30 - 18:00 | 436 | Paediatric bronchology | Oral Presentation |
| 16:30 - 18:00 | 438 | Interstitial lung diseases: from disease mechanisms to novel treatment options | Journal session |
| 16:30 - 18:00 | 439 | Clinical challenges beyond guidelines | Grand round |
| 16:30 - 18:00 | 440 | The environment and climate change effects on lung health across the lifecourse | Hot topics |
| 16:30 - 18:00 | 441 | What is new for sleep apnoea? The European perspective: findings from the European Sleep Apnoea Database (ESADA) | Symposium |
| 16:30 - 18:00 | 442 | Community-acquired pneumonia: the new perspective in the post-COVID era | Symposium |
| 16:30 - 18:00 | 443 | Late breaking basic and translational science of SARS-Cov2 and COVID-19 | Oral Presentation |